Advances in Therapy Pharmacology (medical)

A Time and Motion Study Comparing Subcutaneous Pembrolizumab Versus Intravenous Pembrolizumab in Combination with Chemotherapy for the Treatment of Metastatic Non-small Cell Lung Cancer

Erwin De Cock, Sabine Oskar, Cecilia Lourdudoss, Renata Eiras, M. Catherine Pietanza, Ashwini Arunachalam, Gustavo Alves, Gaston Lucas Martinengo, Enriqueta Felip
Springer Nature · 2025-10-21 · DOI 10.1007/s12325-025-03365-7

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →